Response to Dr. Miller

Re: Response to “Statin-associated myopathy,” published in Research, July 7 1. With the selection criteria clearly stated and concomittant medication disclosed, we fail to see why our study should be considered “deeply flawed.” Or indeed more “flawed” than numerous existing studies, which are based on a fraction of the number of our carefully documented cases. We also regret the lurid reports by the popular press, however, we must decline all responsibility. Tabloids publish what they want.